Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5844069 | Pharmacology & Therapeutics | 2011 | 19 Pages |
Abstract
Serotonin (5-hydroxytryptamine, 5-HT) was one of the first neurotransmitters for which a role in development was identified. Pharmacological and gene knockout studies have revealed a critical role for 5-HT in numerous processes, including cell division, neuronal migration, differentiation and synaptogenesis. An excess in brain 5-HT appears to be mechanistically linked to abnormal brain development, which in turn is associated with neurological disorders. Ambient levels of 5-HT are controlled by a vast orchestra of proteins, including a multiplicity of pre- and post-synaptic 5-HT receptors, heteroreceptors, enzymes and transporters. The 5-HT transporter (SERT, 5-HTT) is arguably the most powerful regulator of ambient extracellular 5-HT. SERT is the high-affinity uptake mechanism for 5-HT and exerts tight control over the strength and duration of serotonergic neurotransmission. Perturbation of its expression level or function has been implicated in many diseases, prominent among them are psychiatric disorders. This review synthesizes existing information on the ontogeny of SERT during embryonic and early postnatal development though adolescence, along with factors that influence its expression and function during these critical developmental windows. We integrate this knowledge to emphasize how inappropriate SERT expression or its dysregulation may be linked to the pathophysiology of psychiatric, cardiovascular and gastrointestinal diseases.
Keywords
IBSserotonin transporter linked polymorphic regionCpGVMAT2DATmonocrotalineDRNMCTPMAT+/−5-HTTLPRMDMAnorepinephrine transporter+/+−/−3,4-methylenedioxymethamphetamine5-HT, serotoninMAPKDopamine transporterOntogenyGene variantsOctpsychiatric diseaseorganic cation transporterNETAntidepressantsDopaminegestational dayembryonic daypostnatal dayserotonin transporterirritable bowel syndromeCytosine-phosphate-guanosineplasma membrane monoamine transporterSelective serotonin reuptake inhibitorSSRIVesicular monoamine transporter-2HPAknockoutnorepinephrinewildtypeheterozygotedorsal raphe nucleusgestational weekhypothalamic–pituitary–adrenalmitogen activated protein kinaseSingle nucleotide polymorphismsSNP
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Lynette C. Daws, Georgianna G. Gould,